Shenzhen Hepalink Pharmaceutical Group
1998
FOUNDED
PUBLIC
STATUS
1K-5K
EMPLOYEES
002399
STOCK SYMBOL
9
INVESTMENTS
$2.40
SHARE PRICE
(As of Wednesday Closing)
Description
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in the supply of heparin sodium drugs. The company distributes its products both in the domestic and overseas markets. Its projects portfolio includes National Bio-High Technology Industrialization Demonstration, the National Torch Program, and the National Key Technology Innovation Project.
Website
Formerly Known As
Shenzhen Hepalink Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Stock Exchange
SHE
Primary Office
- 21 Langshan Road
- Songpingshan
- Shenzhen, Nanshan District 518057
- China
+86 0755 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Hepalink Pharmaceutical Group’s full profile, request a free trial.
Shenzhen Hepalink Pharmaceutical Group Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.12 - $4.22 | $2.99B | $2.43 | $0.10 | 6.19M | 1.25B |
Shenzhen Hepalink Pharmaceutical Group Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 3,725,015 | 4,443,331 | 2,813,659 | 2,893,560 |
| Revenue | 672,162 | 727,855 | 420,749 | 339,437 |
| EBITDA | 177,410 | 162,949 | 56,785 | 83,758 |
| Net Income | 121,663 | 93,147 | 29,101 | 59,586 |
| Total Assets | 2,078,520 | 1,985,039 | 2,162,630 | 1,859,729 |
| Total Debt | 694,786 | 644,125 | 537,876 | 368,400 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Shenzhen Hepalink Pharmaceutical Group Investments & Acquisitions (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000 00 | 27-Feb-2018 | 00000 0000000 | Other Healthcare Services | 00 00 | |
| 00000000000 | 04-Dec-2017 | 0000 | 0000 | Biotechnology | |
| 00000000000 | 20-Jun-2017 | 000000 0000000000 | 00.000 | Biotechnology | |
| 00000 | 24-Nov-2016 | 00000 00000 00 | 00000 | Drug Discovery | |
| OncoVent | 16-Mar-2016 | Joint Venture | 00.00 | Biotechnology |
Shenzhen Hepalink Pharmaceutical Group Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 00000000000 | 01-Aug-2015 | 00000 00000 00 | 00.000 | Completed |
|
Shenzhen Hepalink Pharmaceutical Group Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000 | Pharmaceuticals | 0000 |
Shenzhen Hepalink Pharmaceutical Group Executive Team (4)
Shenzhen Hepalink Pharmaceutical Group Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00 000000 | Shenzhen Hepalink Pharmaceutical Group | Vice President, Board Member & Board Secretary | 000 0000 | |
| 00 00 | Shenzhen Hepalink Pharmaceutical Group | Co-Founder, President & Chairman of Board | 000 0000 | |
| 00 000 | Shenzhen Hepalink Pharmaceutical Group | Co-Founder, Director & Deputy General Manager | 000 0000 | |
| 00000 00000000 | Shenzhen Hepalink Pharmaceutical Group | Independent Director | 000 0000 | |
| 00000 00000 | Shenzhen Hepalink Pharmaceutical Group | Chairman of the Supervisory Board | 000 0000 |
1 Former Board Member
You’re viewing 5 of 6 board members. Get the full list »